M.GreigN
Previous studies show that GLP-1 receptor agonist treatment reduced microglial activation and reverse lipopolysaccharide (LPS)-induced inflammation in the hippocampus (36,88,89), indicating that these properties are preserved in its conjugated form
This meal plan gives you the "what to eat." For the complete story on "why it works," side effect management strategies, and protein preservation science, read our Ultimate Guide to the GLP-1 Diet
Children presenting neurological signs or symptoms, those unable to take oral medication, individuals with known malabsorption syndromes, infants under 6 months old, and patients using medications that may interfere with vitamin B12 absorption are typically treated with a parenteral protocol (1)
This approach takes longer but provides crucial information
CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis